Joseph Schwartz analyst LEERINK

Currently out of the existing stock ratings of Joseph Schwartz, 40 are a HOLD (17.78%), 180 are a BUY (80%), 5 are a SELL (2.22%).

Joseph Schwartz

Work Performance Price Targets & Ratings Chart

Analyst Joseph Schwartz works at LEERINK with a stock forecast success ratio of 52.78% fulfilled within 272.98 days on average.

Joseph Schwartz’s has documented 459 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SYBX, Synlogic at 09-Feb-2024.

Wall Street Analyst Joseph Schwartz

Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES LLC).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 4/26/2016. The price target of $13 was fulfilled within 2 days with a profit of $1.98 (17.97%) receiving and performance score of 89.84.

Average potential price target upside

AMAG AMAG Pharmaceuticals ARNA Arena Pharmaceuticals ASND Ascendis Pharma AS AUPH Aurinia Pharmaceuticals BMRN Biomarin Pharmaceutical CCXI ChemoCentryx FOLD Amicus Therapeutics ICPT Intercept Pharmaceuticals MDCO The Medicines Company PTGX Protagonist Therapeutics QURE Uniqure NV RARE Ultragenyx SLDB Solid Biosciences LLC SPRB Spruce Biosciences  SRPT Sarepta Therapeutics AMTI Applied Molecular Transport  BIIB Biogen CBAY Cymabay Therapeu ACHN Achillion Pharmaceuticals EWTX Edgewise Therapeutics GOSS Gossamer Bio IFRX InflaRx N.V. IMRA Imara INSM Insmed ONCE Spark Therapeutics RETA Reata Pharmaceuticals RPHM Reneo Pharmaceuticals BOLD Audentes Therapeutics DSGN Design Therapeutics PHVS Pharvaris BV RNA Avidity Biosciences  TVTX Travere Therapeutics UTHR United Therapeutics ZFGN Zafgen KALV Kalvista Pharmaceuticals REGN Regeneron Pharmaceuticals SYBX Synlogic ALDR Alder BioPharmaceuticals CRNX Crinetics Pharmaceuticals KDNY Chinook Therapeutics PTI Proteostasis Therapeutics RTRX Travere Therapeutics ANTX AN2 Therapeutics

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score




3 years 4 months 23 days ago

13/18 (72.22%)

$0.67 (5.12%)




$-6.75 (-49.09%)


3 years 6 months 10 days ago

5/8 (62.5%)

$-3.63 (-34.15%)




$-3.75 (-27.27%)


3 years 6 months 10 days ago

1/5 (20%)

$-0.63 (-5.93%)



3 years 6 months 21 days ago

2/6 (33.33%)

$1.9 (8.23%)




$-0.75 (-5.45%)


4 years 9 months 21 days ago

4/5 (80%)

$2.57 (24.64%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Joseph Schwartz is most bullish on?

Potential upside of $3.85 has been obtained for SPRB (SPRUCE BIOSCIENCES )

Which stock is Joseph Schwartz is most reserved on?

Potential downside of -$0.89 has been obtained for SYBX (SYNLOGIC)

What Year was the first public recommendation made by Joseph Schwartz?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?